# Binding pose depth modulates photoswitchable ligands’ efficacy at the 5-HT2A receptor

**Authors:** Verena Weber, Giacomo Salvadori, Federico Natale, Hubert Gerwe, Michael Decker, Paolo Carloni, Giulia Rossetti

PMC · DOI: 10.1038/s42004-026-01936-5 · Communications Chemistry · 2026-02-12

## TL;DR

This study shows how the depth of a drug's binding in a brain receptor affects its effectiveness when controlled by light.

## Contribution

The study identifies ligand insertion depth as a key factor in determining efficacy of photoswitchable ligands at the 5-HT2A receptor.

## Key findings

- Compound 1 (para-methoxy) acts as an antagonist in trans form and an agonist in cis form.
- Compound 2 (meta-methoxy) maintains agonist activity in both isomers, with cis-2 showing highest efficacy.
- Ligand insertion depth correlates with agonist activity and interaction with key receptor residues.

## Abstract

Photoswitchable ligands enable reversible control of receptor signaling through light-induced cis–trans isomerization, yet predicting how subtle structural modifications affect efficacy remains challenging. Here, we use molecular dynamics simulations to investigate two azobenzene-based human 5–HT2A receptor ligands differing only by a methoxy substituent position (para– vs meta–methoxy). Compound 1 (para–methoxy) switches from acting as a weak antagonist (trans) to a moderate agonist (cis), whereas compound 2 (meta-methoxy) maintains agonist activity in both forms, with cis-2 exhibiting the highest efficacy. Our simulations reveal that the key determinant of these efficacy differences lies in the vertical depth of ligand insertion into the orthosteric binding pocket. The para–methoxy moiety of trans–1 forms hydrogen bonds with Asp2315.35 and Thr1603.37, anchoring the ligand deeper than typical tryptamine agonists and preventing engagement with activation-critical residues, thereby stabilizing the inactive receptor. Conversely, trans–2 lacks these anchoring interactions and adopts a shallower, agonist-compatible pose. In the active receptor, cis–2 forms a persistent Thr1603.37 hydrogen bond that allows deeper penetration between TM4 and TM5, whereas cis–1’s para–methoxy causes steric hindrances limiting this interaction. Based on these findings, we suggest that ligand insertion depth is a critical determinant of efficacy. This provides a framework for designing light-sensitive GPCR ligands with tunable signaling properties.

Photoswitchable ligands can reversibly modulate receptor activity upon light-induced isomerization, yet the impact of structural changes on efficacy is not well understood. Here, the authors use molecular dynamics simulations to investigate two azobenzene-based 5–HT2A receptor ligands with different methoxy substituent positions, revealing that ligand insertion depth into the binding pocket is a crucial determinant of efficacy.

## Linked entities

- **Chemicals:** azobenzene (PubChem CID 2272), methoxy (PubChem CID 123146)

## Full-text entities

- **Genes:** GPR166P (G protein-coupled receptor 166, pseudogene) [NCBI Gene 442206] {aka GPCR, PGR9}, HTR2A (5-hydroxytryptamine receptor 2A) [NCBI Gene 3356] {aka 5-HT2A, HTR2}
- **Chemicals:** TM4 (-), azobenzene (MESH:C009850), tryptamine (MESH:C030820)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12992696/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12992696/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12992696/full.md

---
Source: https://tomesphere.com/paper/PMC12992696